Overview of the Tourmaline-MM1 study in relapsed/refractory multiple myeloma

Paul Richardson, MD from the Dana-Farber Cancer Institute Medical Oncology, Boston, MA provides an overview of the Tourmaline-MM1 study of ixazomib in combination with lenalidomide and dexamethasone i... Author: VJHemOnc Added: 02/11/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts